Kim et al. [43] found that the MAPK signaling pathway is implicated in the development of AD through the regulation of phosphorylation of Amyloid Beta Precursor Protein (APP) and Tau, the main contents in CSF. This evidence concerns the gene MAPT and Alzheimer disease.